Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
udenafil
|
| gptkbp:approvalYear |
2005
|
| gptkbp:approvedBy |
gptkb:South_Korea
|
| gptkbp:ATCCode |
gptkb:G04BE09
|
| gptkbp:chemicalClass |
udenafil
|
| gptkbp:contraindication |
nitrate medications
|
| gptkbp:countryOfOrigin |
gptkb:South_Korea
|
| gptkbp:drugClass |
PDE5 inhibitor
|
| gptkbp:halfLife |
7.3-12.1 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zydena
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Dong-A_Pharmaceutical
|
| gptkbp:marketedAs |
gptkb:Zydena
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
nasal congestion dyspepsia flushing |
| gptkbp:usedFor |
erectile dysfunction
|
| gptkbp:bfsParent |
gptkb:Udenafil
|
| gptkbp:bfsLayer |
7
|